anaplastic lymphoma kinase gene rearranged non-small-cell lung
Definition: A fusion protein resulting from the rearrangement of the EML4 gene with the ALK gene, present in approximately 5% of non-small-cell lung cancers, primarily adenocarcinomas. This fusion protein is a target of ALK tyrosine kinase inhibitors in the treatment of these tumors.
Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.
Search Stedman's Medical Dictionary
Examples: glitazone, GI cocktail, etc.
© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review Date: Sep 19, 2016.